ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth
03 oct. 2024 08h00 HE
|
ViaDerma, Inc.
ViaDerma post strong Q2 results
ViaDerma Completes First Shipment of 500,000 Units to Nigeria
10 sept. 2024 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
13 août 2024 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
01 août 2024 08h00 HE
|
ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
ViaDerma Provides Highlights of Quarterly Financial Report
06 juin 2024 08h00 HE
|
ViaDerma, Inc.
ViaDerma provides an update on their most recent quarterly financial report
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
24 oct. 2023 10h30 HE
|
ViaDerma, Inc.
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders,...
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More
06 juil. 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and...
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
16 mars 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair...
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
08 mars 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, March 08, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce their plans to launch a new hair regrowth product using Minoxidil (topical route). The company...
ViaDerma Provides an Update on Current & Future Business Activities
02 mars 2023 08h00 HE
|
ViaDerma, Inc.
LOS ANGELES, March 02, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to provide an update on current business activities. ViaDerma has expanded its licensing agreement with a...